Análisis del catabolismo muscular en la enfermedad pulmonar obstructiva crónica

World Health Organization, 2000 Gea, 2008, Actualización en los mecanismos de disfunción muscular en la EPOC, Arch Bronconeumol, 44, 328, 10.1016/S0300-2896(08)70441-1 Bolton, 2004, Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 170, 1286, 10.1164/rccm.200406-754OC Caro de Miguel, 2009, Relación entre la masa libre de grasa, la masa muscular, la fuerza de contracción voluntaria máxima del cuadriceps y el test de la marcha de 6 minutos en pacientes con enfermedad pulmonar obstructiva crónica, Rev Patol Resp, 12, 159 Coronell, 2004, Relevance of assessing quadriceps endurance in patients with COPD, Eur Respir J, 24, 129, 10.1183/09031936.04.00079603 Maltais, 2000, Peripheral muscle dysfunction in chronic obstructive pulmonary disease, Clinics in Chest Medicine, 21, 665, 10.1016/S0272-5231(05)70176-3 Laghi, 2009, Endocrinological derangements in COPD, Eur Respir J, 34, 975, 10.1183/09031936.00103708 Engelen, 2003, Response of whole-body protein and urea turnover to exercisediffers between patients wih chronic obstructive pulmonary disease with and without emphysema, Am J Clin Nutr, 77, 868, 10.1093/ajcn/77.4.868 Celli, 2001, The COPD staging system combining 6mwd, fev1, dyspnea and BMI is a better predical of mortality than FEV1, Am J Respir Crit Care Med, 163, A504 Boreck, 1972, Atypical transfer RNAS and their origin in neoplastic cells, Adv Cancer Res, 15, 163, 10.1016/S0065-230X(08)60374-7 Ionescu, 2000, Pulmonary function, body composition and protein catabolism in adults with cystic fibrosis, Am J Respir Crit Care Med, 165, 495, 10.1164/ajrccm.165.4.2104065 Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, 2001. Disponible en: URL http://www.goldcopd.com. Cabanes Mariscal, 2008, Desarrollo y validación de un método de cromatografía líquida de alta resolución (HPLC) para la determinación de pseudouridina en orina. Posible marcador en el diagnóstico precoz y control de la terapia en la enfermedad pulmonar obstructiva crónica, Farm Hosp, 32, 3 ICH. International Conference of Harmonisation of technical requirements for registration of pharmaceutical for human use. Validation of analytical procedures: methodology. 6 Noviembre 1996. Sjolin, 1982, Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography, Urol Res, 10, 245, 10.1007/BF00255930 Seidel, 2006, Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control, Brit J Cancer, 94, 1726, 10.1038/sj.bjc.6603164 Bolton, 2007, Cellular protein breackdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD, Thorax, 62, 109, 10.1136/thx.2006.060368 Debigare, 2003, Catabolic/anabolic balance and muscle wasting in patients with COPD, Chest, 124, 83, 10.1378/chest.124.1.83 Salvatore, 1983, Pseudouridine determination in blood serum as tumour marker, Cancer Detect Prev, 6, 831 Intrieri, 1996, Pseudouridine and 1-Rybosylpiridin-4-One-3- Carboxamide (PCNR) serum concentrations in human inmunodeficiency virus type 1-infected patients are independent predictors for AIDS progression, J Infect Dis, 174, 199, 10.1093/infdis/174.1.199 Montenegro Álvarez de Tejera, 2009, Influencia del tabaco en el índice pseudouridina/creatinina. Estudio piloto, Rev Patol Respir, 12, 119 Man, 2009, Skeletal muscle dysfunction in COPD: clinical and laboratory observations, Clin Sci, 117, 261, 10.1042/CS20080659 Doucet, 2007, Muscle atrophy and hypertrophy signalling in patients with chronic obstructive pulmonary disease, Am J Resp Crit Care Med, 176, 261, 10.1164/rccm.200605-704OC Cepelack, 2006, Enzyme catalytic activities in chronic obstructive pulmonary disease, Arch Med Res, 37, 624, 10.1016/j.arcmed.2006.01.004 Engelen, 2000, Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 162, 1488, 10.1164/ajrccm.162.4.2002045 Tolep, 1993, Effect of aging on respiratory skeletal muscles, Clinic Chest Med, 14, 363, 10.1016/S0272-5231(21)00901-1 Gallager, 1997, Appendicular skeletal muscle mass: effects of age, gender and ethnicity, J Apply Physiol, 83, 229, 10.1152/jappl.1997.83.1.229 Dorrens, 2003, Effects of ageing and human whole body and muscle protein turnover, Scand J Med Sci, 13, 26, 10.1034/j.1600-0838.2003.00306.x